An article in the June 2009 issue (“Use Cardio Risk Guidelines Along With Antipsychotics,” p. 24) incorrectly characterized the impact of quetiapine on triglyceride levels based on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) findings. The CATIE data show that increases—not decreases—in nonfasting triglyceride levels were found among subjects randomized to quetiapine (Schizophrenia Research 2008;103:104-9).
PREVIEW